Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1994-12-20
|
pubmed:abstractText |
Of 798 hepatitis B virus (HBV) carriers, 22 had low titers (lower than 80% inhibition in 200- or 400-fold diluted serum) of antibody to hepatitis B core antigen (anti-HBc). Among these 22 patients, there were 12 (1.50%) with viremia who were positive for hepatitis B e antigen and had a high titer of HBV-associated DNA polymerase activity. Among these 12 patients, four showed no significant change in the anti-HBc titer, while four others showed significant increases in the anti-HBc titer during the follow-up periods. The former all remained asymptomatic carriers (ASCs), while the latter all developed chronic hepatitis (CH). The liver histology of four patients (ASC: 2, CH: 2) showed mild inflammation, and the localization of hepatitis B core antigen (HBcAg) in the liver specimens showed a nuclear pattern in the two ASCs, but a nuclear plus cytoplasmic pattern in the two CH cases. In HBV carriers, the increase in anti-HBc titer seems to be closely correlated to the change in HBcAg localization from the nucleus to the cytoplasm in the liver. Therefore, rising titers of anti-HBc were assumed to be associated with increased expression of HBcAg on the hepatocyte, and hence increased immune-mediated hepatic damage and the onset of hepatitis in ASC with low titer of anti-HBc.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Directed DNA Polymerase,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B Core Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B e Antigens
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0172-6390
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
235-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7959545-Adolescent,
pubmed-meshheading:7959545-Adult,
pubmed-meshheading:7959545-Aged,
pubmed-meshheading:7959545-Carrier State,
pubmed-meshheading:7959545-Chronic Disease,
pubmed-meshheading:7959545-DNA-Directed DNA Polymerase,
pubmed-meshheading:7959545-Female,
pubmed-meshheading:7959545-Follow-Up Studies,
pubmed-meshheading:7959545-Hepatitis B,
pubmed-meshheading:7959545-Hepatitis B Antibodies,
pubmed-meshheading:7959545-Hepatitis B Core Antigens,
pubmed-meshheading:7959545-Hepatitis B e Antigens,
pubmed-meshheading:7959545-Humans,
pubmed-meshheading:7959545-Liver,
pubmed-meshheading:7959545-Male,
pubmed-meshheading:7959545-Middle Aged,
pubmed-meshheading:7959545-Viremia
|
pubmed:year |
1994
|
pubmed:articleTitle |
Hepatitis B virus carrier with low titer of antibody to hepatitis B core antigen.
|
pubmed:affiliation |
Department of Medicine, Osaka Kosei-Nenkin Hospital, Japan.
|
pubmed:publicationType |
Journal Article
|